全文获取类型
收费全文 | 406篇 |
免费 | 32篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 11篇 |
妇产科学 | 11篇 |
基础医学 | 46篇 |
临床医学 | 32篇 |
内科学 | 49篇 |
皮肤病学 | 14篇 |
神经病学 | 103篇 |
特种医学 | 5篇 |
外科学 | 53篇 |
综合类 | 4篇 |
预防医学 | 34篇 |
眼科学 | 8篇 |
药学 | 36篇 |
中国医学 | 1篇 |
肿瘤学 | 28篇 |
出版年
2024年 | 1篇 |
2023年 | 10篇 |
2022年 | 17篇 |
2021年 | 31篇 |
2020年 | 9篇 |
2019年 | 32篇 |
2018年 | 30篇 |
2017年 | 16篇 |
2016年 | 12篇 |
2015年 | 11篇 |
2014年 | 15篇 |
2013年 | 24篇 |
2012年 | 37篇 |
2011年 | 26篇 |
2010年 | 16篇 |
2009年 | 13篇 |
2008年 | 24篇 |
2007年 | 15篇 |
2006年 | 16篇 |
2005年 | 19篇 |
2004年 | 13篇 |
2003年 | 13篇 |
2002年 | 14篇 |
2001年 | 4篇 |
2000年 | 2篇 |
1999年 | 4篇 |
1998年 | 3篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1991年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有438条查询结果,搜索用时 0 毫秒
71.
Serge Mignani Jean‐Claude Aloup Michel Barreau Jean Charles Blanchard Georg Andrees Bhme Alain Boireau Dominique Damour Marc‐Williams Debono Marie‐Christine Dubroeucq Arielle Genevois‐Borella Assunta Imperato Patrick Jimonet Jeremy Pratt John C.R. Randle Michel Reibaud Yves Ribeill Jean‐Marie Stutzmann 《Drug development research》1999,48(3):121-129
The excessive release of glutamate, a potent excitatory neurotransmitter, is thought to play an important role in a variety of acute and chronic neurological disorders. Consequently, excitatory amino acid antagonists may have an important therapeutic potential in the treatment of these diseases. Glutamate interacts with at least three types of receptor: 1) NMDA (N‐methyl‐D‐aspartic acid) receptors; 2) AMPA [2‐amino‐3‐(3‐hydroxy‐5‐methylisoxazol‐4‐yl)propionic acid]/kainic acid (KA) receptors; and 3) metabotropic receptors. Blockade of ionotropic AMPA/KA receptors has been shown to prevent cerebral ischemia insult in experimental models. This article describes the synthesis, pharmacological activity, and neuroprotective properties of 5H,10H‐imidazo[1,2‐a]indeno[1,2‐e]pyrazine‐4‐one ( 1 ), a novel AMPA/KA antagonist which showed micromolar affinity at AMPA/KA receptors and competitively inhibited functional responses mediated by these receptors. In mice, 1 had significant anticonvulsive properties and conferred protection against hypobaric hypoxia and KCN intoxication. In rats and gerbils, 1 possesses significant activity in models of global or focal cerebral ischemia, as well as in a model of neurotrauma. Compound 1 was prepared from 2‐bromo‐indanone using two synthetic pathways in two or three steps with moderate (30%) or good (70%) yields, respectively. Drug Dev. Res. 48:121–129, 1999. © 1999 Wiley‐Liss, Inc. 相似文献
72.
73.
Lithium-pilocarpine, a relevant model of temporal lobe epilepsy was used to test the neuroprotective and antiepileptogenic effects of carisbamate. Status epilepticus (SE) was induced in adult rats by lithium and pilocarpine. Carisbamate (30, 60, 90, and 120?mg/kg) was injected at 1 and 9?h after SE onset and continued twice daily for 6 additional days. The reference groups received diazepam instead of carisbamate. Neuroprotection was assessed during the first 24?h of SE with Fluoro-Jade B and after 14 days with thionine staining. SE severity and epileptic outcome were assessed by video, and surface and depth electroencephalographic recordings. At the two highest doses, carisbamate treatment reduced SE severity; produced strong neuroprotection of hippocampus, ventral cortices, thalamus, and amygdala; prevented mossy fiber sprouting in the dentate gyrus of the hippocampus; and delayed or suppressed the occurrence of spontaneous motor seizures. Rats with no spontaneous motor seizures displayed spike-and-wave discharges that share all the characteristics of absence seizures. In conclusion, carisbamate is able to induce strong neuroprotection and affect the nature of epileptogenic events occurring during and after lithium-pilocarpine status epilepticus, reflecting marked insult- and disease-modifying effects. 相似文献
74.
75.
76.
Lang Kuhs KA Toporovski R Ginsberg AA Olsen AL Shedlock DJ Morrow MP Yan J Wells RG Weiner DB 《Human vaccines》2011,7(12):1326-1335
It is believed that an effective HCV vaccine must induce strong HCV-specific cytotoxic IFN-γ? CD8? T cells able to migrate into and become fully activated within the liver, an organ known to suppress T cell responses and induce tolerance. Given the importance of intrahepatic HCV-specific T cells in the clearance of acute infection, the goal of this present study was to determine if peripheral immunization was able to induce functional intrahepatic HCV-specific T cell based immunity both in the presence and absence of HCV antigen expression within the liver. Using a novel HCV NS3/NS4A DNA vaccine, we show that peripheral immunization of C57BL/6 mice results in the formation of a large pool of fully functional HCV-specific cytotoxic IFN-γ? CD8? T cells within the liver and that these cells were highly enriched within the liver as compared to the spleen. Following hepatic expression of cognate HCV antigen using a previously described liver transfection method, we show that this pool of vaccine-induced HCV-specific CD8? T cells retained its ability to become highly activated as shown by the upregulation of IFN-γ and CCR5 expression, as well as by the clearance of HCV NS3 expressing hepatocytes. Taken together, these findings suggest that T cell effector function is preserved within the liver and that selective recruitment of antigen-specific T cells to the liver may play a previously unappreciated role in the process of immune surveillance, which may be exploited for future T cell based HCV vaccines. 相似文献
77.
Rationale
Pharmacological activation of GABAB receptors in the dorsal raphe nucleus (DRN) can escalate territorial aggression in male mice.Objectives
We characterized this escalated aggression in terms of its behavioral and environmental determinants.Methods
Aggressive behavior of resident male (CFW or ICR mouse) was assessed in confrontations with a group-housed intruder. Either baclofen (0.06 nmol/0.2 μl) or vehicle (saline) was microinjected into the DRN 10 min before the confrontation. We examined baclofen-heightened aggression in five situations: aggression in a neutral arena and after social instigation (experiment 1), aggression during the light phase of the cycle (experiment 2), aggression without prior fighting experience (experiment 3), aggression toward a female (experiment 4), and aggression after defeat experiences (experiment 5). In addition, we examined the body targets towards which bites are directed and the duration of aggressive bursts after baclofen treatment.Results
Regardless of the past social experience, baclofen escalated aggressive behaviors. Even in the neutral arena and after defeat experiences, where aggressive behaviors were inhibited, baclofen significantly increased aggression. Baclofen increased attack bites directed at vulnerable body areas of male intruders but not toward a female and only in the dark. Also, baclofen prolonged the duration of aggressive bursts.Conclusions
For baclofen to escalate aggression, specific stimulation (male intruder) and tonic level of serotonin (dark cycle) are required. Once aggressive behavior is triggered, intra-DRN baclofen escalates the level of aggression to abnormal levels and renders it difficult to terminate. Also, baclofen counteracts the effects of novelty or past experiences of defeat. 相似文献78.
79.
80.